2024 HCPCS Code Q0173
Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
TAGS: prescription trimethobenzamide chemotherapy exceed substitute regimen approved therapeutic complete dosage
| Short Description | Trimethobenzamide hcl 250mg |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 1998 |
| HCPCS Code Added Date | April 01, 1998 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q5112 - Inj ontruzant 10 mg
- Q5113 - Inj herzuma 10 mg
- Q5114 - Inj ogivri 10 mg
- Q5115 - Inj truxima 10 mg
- Q5116 - Inj., trazimera, 10 mg
- Q5117 - Inj., kanjinti, 10 mg
- Q5118 - Inj., zirabev, 10 mg
- Q5119 - Inj ruxience, 10 mg
- Q5120 - Inj pegfilgrastim-bmez 0.5mg
- Q5121 - Inj. avsola, 10 mg
- Q5122 - Inj, nyvepria
- Q5123 - Inj. riabni, 10 mg
- Q5124 - Inj. byooviz, 0.1 mg
- Q5125 - Inj, releuko 1 mcg
- Q5126 - Inj alymsys 10 mg
- Q5127 - Inj, stimufend, 0.5 mg
- Q5128 - Inj, cimerli, 0.1 mg
- Q5129 - Inj, vegzelma, 10 mg
- Q5130 - Inj, fylnetra, 0.5 mg
- Q5131 - Inj, idacio, 20 mg